[Therapy in Alzheimer disease].
Kovács
Tibor
T
Semmelweis Egyetem, Altalános Orvostudomány Kar, Neurológiai Klinika, Budapest. tibor@neur.sote.hu
D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000523:psychology; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects; D018450:Disease Progression; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D018697:Nootropic Agents / Q000627:therapeutic use*
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002800:Cholinesterase Inhibitors; D018691:Excitatory Amino Acid Antagonists; D006993:Hypnotics and Sedatives; D018697:Nootropic Agents